Serum Metabolic Profiling in a Mouse Model of Adriamycin-Induced Focal Segmental Glomerulosclerosis

Chin Med J (Engl). 2018 Nov 20;131(22):2743-2746. doi: 10.4103/0366-6999.245266.

Authors

Li Lyu¹, Cai-Li Wang², Zeng-Yan Li², Ying-Jin Shi², Yan-Hui Zhang², Yan Mi², Zhao Hu¹

Affiliations

¹ Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
² Department of Nephrology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia 014010, China.

No abstract available

Publication types

Letter

MeSH terms

Animals
Body Weight / physiology
Computational Biology / methods
Disease Models, Animal
Doxorubicin / toxicity*
Fatty Acids, Monounsaturated / blood
Fatty Acids, Monounsaturated / metabolism
Glomerulosclerosis, Focal Segmental / blood*
Glomerulosclerosis, Focal Segmental / chemically induced*
Glomerulosclerosis, Focal Segmental / metabolism
Male
Methoxyhydroxyphenylglycol / analogs & derivatives
Methoxyhydroxyphenylglycol / blood
Methoxyhydroxyphenylglycol / metabolism
Mice
Mice, Inbred BALB C
Pyridoxine / blood
Pyridoxine / metabolism
Valine / analogs & derivatives
Valine / blood
Valine / metabolism
Vanillic Acid / blood
Vanillic Acid / metabolism

Substances

Fatty Acids, Monounsaturated
palmitoleic acid
3-methoxy-4-hydroxyphenylglycol sulfate
Methoxyhydroxyphenylglycol
Doxorubicin
Vanillic Acid
Valine
Pyridoxine
N-acetylvaline